Nov. 7, 2019 Price forecast | 2 weeks: 6.62% | 1 month: 7.95% | 3 months: 17.64% | Premium Forecast


VXRT stock forecast

Our latest prediction for Vaxart, Inc.'s stock price was made on the Nov. 7, 2019 when the stock price was at 0.33$.

In the short term (2weeks), VXRT's stock price should outperform the market by 6.62%. During that period the price should oscillate between -10.69% and +21.92%.

In the medium term (3months), VXRT's stock price should outperform the market by 17.64%. During that period the price should oscillate between -21.82% and +72.15%.


About Vaxart, Inc.

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.

At the moment the company generates 8M USD in revenues.

On its last earning announcement, the company reported a loss of -2.27$ per share.

The book value per share is 3.13$

Vaxart, Inc. website


Three months stock forecastNov. 7, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
8M - -16M -205.70% -18M -2.27 - - 9M 3.13 -16M -1M -17M